Works by Eberhardt, Wilfried E. E.

Results: 26

Acquired Resistance to BRAF/MEK Inhibitor Therapy in BRAF-V600-mutated Squamous Cell Lung Cancer: Concurrent Evolvement of PTEN and MEK1 Mutations.

Published in:

Clinical Lung Cancer, 2021, v. 22, n. 5, p. e668, doi. 10.1016/j.cllc.2020.11.008

By:

Metzenmacher, Martin;
Goetz, Moritz;
Herold, Thomas;
Stuschke, Martin;
Aigner, Clemens;
Darwiche, Kaid;
Eberhardt, Wilfried E.;
Schuler, Martin;
Wiesweg, Marcel

Publication type:

Article

Rapid and Highly Sensitive Detection of Therapeutically Relevant Oncogenic Driver Mutations in EBUS-TBNA Specimens From Patients With Lung Adenocarcinoma.

Published in:

2018

By:

Oezkan, Filiz;
Herold, Thomas;
Darwiche, Kaid;
Eberhardt, Wilfried E E;
Worm, Karl;
Christoph, Daniel C;
Wiesweg, Marcel;
Freitag, Lutz;
Schmid, Kurt-Werner;
Theegarten, Dirk;
Hager, Thomas;
Koenig, Michael J;
He, Kai;
Taube, Christian;
Schuler, Martin;
Breitenbuecher, Frank

Publication type:

journal article

MET Expression in Advanced Non-Small-Cell Lung Cancer: Effect on Clinical Outcomes of Chemotherapy, Targeted Therapy, and Immunotherapy.

Published in:

2018

By:

Reis, Henning;
Metzenmacher, Martin;
Goetz, Moritz;
Savvidou, Nikoleta;
Darwiche, Kaid;
Aigner, Clemens;
Herold, Thomas;
Eberhardt, Wilfried E;
Skiba, Charlotte;
Hense, Jörg;
Virchow, Isabel;
Westerwick, Daniela;
Bogner, Simon;
Ting, Saskia;
Kasper, Stefan;
Stuschke, Martin;
Nensa, Felix;
Herrmann, Ken;
Hager, Thomas;
Schmid, Kurt W

Publication type:

journal article

Assessment of Folate Receptor-[alpha] and Epidermal Growth Factor Receptor Expression in Pemetrexed-Treated Non-Small-Cell Lung Cancer Patients.

Published in:

2014

By:

Christoph, Daniel C;
Reyna-Asuncion, Bernadette;
Hassan, Biftu;
Tran, Cindy;
Maltzman, Julia D;
O'Shannessy, Daniel J;
Gauler, Thomas C;
Wohlschlaeger, Jeremias;
Schuler, Martin;
Eberhardt, Wilfried E;
Hirsch, Fred R

Publication type:

Journal Article

Assessment of Folate Receptor-α and Epidermal Growth Factor Receptor Expression in Pemetrexed-Treated Non-Small-Cell Lung Cancer Patients.

Published in:

Clinical Lung Cancer, 2014, v. 15, n. 5, p. 320, doi. 10.1016/j.cllc.2014.05.002

By:

Christoph, Daniel C.;
Reyna-Asuncion, Bernadette;
Hassan, Biftu;
Tran, Cindy;
Maltzman, Julia D.;
O'Shannessy, Daniel J.;
Gauler, Thomas C.;
Wohlschlaeger, Jeremias;
Schuler, Martin;
Eberhardt, Wilfried E.;
Hirsch, Fred R.

Publication type:

Article

ERCC1, MLH1, MSH2, MSH6, and βIII-Tubulin: Resistance Proteins Associated With Response and Outcome to Platinum-based Chemotherapy in Malignant Pleural Mesothelioma.

Published in:

Clinical Lung Cancer, 2013, v. 14, n. 5, p. 558, doi. 10.1016/j.cllc.2013.04.013

By:

Ting, Saskia;
Mairinger, Fabian D.;
Hager, Thomas;
Welter, Stefan;
Eberhardt, Wilfried E.;
Wohlschlaeger, Jeremias;
Schmld, Kurt W.;
Christoph, Daniel C.

Publication type:

Article

Patterns of nodal spread in stage III NSCLC: importance of EBUS-TBNA and 18F-FDG PET/CT for radiotherapy target volume definition.

Published in:

2021

By:

Guberina, Maja;
Darwiche, Kaid;
Hautzel, Hubertus;
Pöttgen, Christoph;
Guberina, Nika;
Gauler, Thomas;
Ploenes, Till;
Umutlu, Lale;
Theegarten, Dirk;
Aigner, Clemens;
Eberhardt, Wilfried E. E.;
Metzenmacher, Martin;
Wiesweg, Marcel;
Karpf-Wissel, Rüdiger;
Schuler, Martin;
Herrmann, Ken;
Stuschke, Martin

Publication type:

journal article

68Ga-SSO-120 PET for Initial Staging of Small Cell Lung Cancer Patients: A Single-Center Retrospective Study.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 10, p. 1540, doi. 10.2967/jnumed.123.265664

By:

Kersting, David;
Sandach, Patrick;
Sraieb, Miriam;
Wiesweg, Marcel;
Metzenmacher, Martin;
Darwiche, Kaid;
Oezkan, Filiz;
Bölukbas, Servet;
Stuschke, Martin;
Umutlu, Lale;
Nader, Michael;
Hamacher, Rainer;
Fendler, Wolfgang P.;
Wienker, Johannes;
Eberhardt, Wilfried E. E.;
Schuler, Martin;
Herrmann, Ken;
Hautzel, Hubertus

Publication type:

Article

PROGNOSTIC VALUE OF POST-INDUCTION CHEMOTHERAPY VOLUMETRIC PET/CT PARAMETERS FOR STAGE IIIA/B NON-SMALL CELL LUNG CANCER PATIENTS RECEIVING DEFINITIVE CHEMORADIOTHERAPY.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.120.260646

By:

Guberina, Maja;
Pöttgen, Christoph;
Metzenmacher, Martin;
Wiesweg, Marcel;
Schuler, Martin;
Aigner, Clemens;
Ploenes, Till;
Umutlu, Lale;
Gauler, Thomas;
Darwiche, Kaid;
Stamatis, Georgios;
Theegarten, Dirk;
Hautzel, Hubertus;
Jentzen, Walter;
Guberina, Nika;
Herrmann, Ken;
Eberhardt, Wilfried E. E.;
Stuschke, Martin

Publication type:

Article

PROGNOSTIC VALUE OF POST-INDUCTION CHEMOTHERAPY VOLUMETRIC PET/CT PARAMETERS FOR STAGE IIIA/B NON-SMALL CELL LUNG CANCER PATIENTS RECEIVING DEFINITIVE CHEMORADIOTHERAPY.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.120.260646

By:

Guberina, Maja;
Pöttgen, Christoph;
Metzenmacher, Martin;
Wiesweg, Marcel;
Schuler, Martin;
Aigner, Clemens;
Ploenes, Till;
Umutlu, Lale;
Gauler, Thomas;
Darwiche, Kaid;
Stamatis, Georgios;
Theegarten, Dirk;
Hautzel, Hubertus;
Jentzen, Walter;
Guberina, Nika;
Herrmann, Ken;
Eberhardt, Wilfried E. E.;
Stuschke, Martin

Publication type:

Article

PROGNOSTIC VALUE OF POST-INDUCTION CHEMOTHERAPY VOLUMETRIC PET/CT PARAMETERS FOR STAGE IIIA/B NON-SMALL CELL LUNG CANCER PATIENTS RECEIVING DEFINITIVE CHEMORADIOTHERAPY.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.260646

By:

Guberina, Maja;
Pöttgen, Christoph;
Metzenmacher, Martin;
Wiesweg, Marcel;
Schuler, Martin;
Aigner, Clemens;
Ploenes, Till;
Umutlu, Lale;
Gauler, Thomas;
Darwiche, Kaid;
Stamatis, Georgios;
Theegarten, Dirk;
Hautzel, Hubertus;
Jentzen, Walter;
Guberina, Nika;
Herrmann, Ken;
Eberhardt, Wilfried E. E.;
Stuschke, Martin

Publication type:

Article

PROGNOSTIC VALUE OF POST-INDUCTION CHEMOTHERAPY VOLUMETRIC PET/CT PARAMETERS FOR STAGE IIIA/B NON-SMALL CELL LUNG CANCER PATIENTS RECEIVING DEFINITIVE CHEMORADIOTHERAPY.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.120.260646

By:

Guberina, Maja;
Pöttgen, Christoph;
Metzenmacher, Martin;
Wiesweg, Marcel;
Schuler, Martin;
Aigner, Clemens;
Ploenes, Till;
Umutlu, Lale;
Gauler, Thomas;
Darwiche, Kaid;
Stamatis, Georgios;
Theegarten, Dirk;
Hautzel, Hubertus;
Jentzen, Walter;
Guberina, Nika;
Herrmann, Ken;
Eberhardt, Wilfried E. E.;
Stuschke, Martin

Publication type:

Article

PROGNOSTIC VALUE OF POST-INDUCTION CHEMOTHERAPY VOLUMETRIC PET/CT PARAMETERS FOR STAGE IIIA/B NON-SMALL CELL LUNG CANCER PATIENTS RECEIVING DEFINITIVE CHEMORADIOTHERAPY.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.120.260646

By:

Guberina, Maja;
Pöttgen, Christoph;
Metzenmacher, Martin;
Wiesweg, Marcel;
Schule, Martin;
Aigner, Clemens;
Ploenes, Till;
Umutlu, Lale;
Gauler, Thomas;
Darwiche, Kaid;
Stamatis, Georgios;
Theegarten, Dirk;
Hautzel, Hubertus;
Jentzen, Walter;
Guberina, Nika;
Herrmann, Ken;
Eberhardt, Wilfried E. E.;
Stuschke, Martin

Publication type:

Article

PROGNOSTIC VALUE OF POST-INDUCTION CHEMOTHERAPY VOLUMETRIC PET/CT PARAMETERS FOR STAGE IIIA/B NON-SMALL CELL LUNG CANCER PATIENTS RECEIVING DEFINITIVE CHEMORADIOTHERAPY.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 31, doi. 10.2967/jnumed.120.260646

By:

Guberina, Maja;
Pöttgen, Christoph;
Metzenmacher, Martin;
Wiesweg, Marcel;
Schuler, Martin;
Aigner, Clemens;
Ploenes, Till;
Umutlu, Lale;
Gauler, Thomas;
Darwiche, Kaid;
Stamatis, Georgios;
Theegarten, Dirk;
Hautzel, Hubertus;
Jentzen, Walter;
Guberina, Nika;
Herrmann, Ken;
Eberhardt, Wilfried E. E.;
Stuschke, Martin

Publication type:

Article

Impact of metallothionein-knockdown on cisplatin resistance in malignant pleural mesothelioma.

Published in:

Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-75807-x

By:

Borchert, Sabrina;
Suckrau, Pia-Maria;
Walter, Robert F. H.;
Wessolly, Michael;
Mairinger, Elena;
Steinborn, Julia;
Hegedus, Balazs;
Hager, Thomas;
Herold, Thomas;
Eberhardt, Wilfried E. E.;
Wohlschlaeger, Jeremias;
Aigner, Clemens;
Bankfalvi, Agnes;
Schmid, Kurt Werner;
Mairinger, Fabian D.

Publication type:

Article

Long-Term Survival in Patients with Oligometastatic Non-Small Cell Lung Cancer by a Multimodality Treatment—Comparison with Stage III Disease.

Published in:

Cancers, 2024, v. 16, n. 6, p. 1174, doi. 10.3390/cancers16061174

By:

Guberina, Maja;
Pöttgen, Christoph;
Guberina, Nika;
Hoffmann, Christian;
Wiesweg, Marcel;
Richlitzki, Cedric;
Metzenmacher, Martin;
Aigner, Clemens;
Bölükbas, Servet;
Gauler, Thomas;
Eberhardt, Wilfried E. E.;
Forsting, Michael;
Herrmann, Ken;
Theegarten, Dirk;
Darwiche, Kaid;
Jendrossek, Verena;
Stuschke, Martin;
Schuler, Martin

Publication type:

Article

Gene expression profiling of homologous recombination repair pathway indicates susceptibility for olaparib treatment in malignant pleural mesothelioma in vitro.

Published in:

2019

By:

Borchert, Sabrina;
Wessolly, Michael;
Schmeller, Jan;
Mairinger, Elena;
Kollmeier, Jens;
Hager, Thomas;
Mairinger, Thomas;
Herold, Thomas;
Christoph, Daniel C.;
Walter, Robert F. H.;
Eberhardt, Wilfried E. E.;
Plönes, Till;
Wohlschlaeger, Jeremias;
Aigner, Clemens;
Schmid, Kurt Werner;
Mairinger, Fabian D.

Publication type:

journal article

C-reactive protein as robust laboratory value associated with prognosis in patients with stage III non-small cell lung cancer (NSCLC) treated with definitive radiochemotherapy.

Published in:

Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-64302-2

By:

Richlitzki, Cedric;
Wiesweg, Marcel;
Metzenmacher, Martin;
Guberina, Nika;
Pöttgen, Christoph;
Hautzel, Hubertus;
Eberhardt, Wilfried E. E.;
Darwiche, Kaid;
Theegarten, Dirk;
Aigner, Clemens;
Bölükbas, Servet;
Schuler, Martin;
Stuschke, Martin;
Guberina, Maja

Publication type:

Article

N-staging in large cell neuroendocrine carcinoma of the lung: diagnostic value of [18F]FDG PET/CT compared to the histopathology reference standard.

Published in:

EJNMMI Research, 2021, v. 11, n. 1, p. 1, doi. 10.1186/s13550-021-00811-9

By:

Hautzel, Hubertus;
Alnajdawi, Yazan;
Fendler, Wolfgang P.;
Rischpler, Christoph;
Darwiche, Kaid;
Eberhardt, Wilfried E.;
Umutlu, Lale;
Theegarten, Dirk;
Stuschke, Martin;
Schuler, Martin;
Aigner, Clemens;
Herrmann, Ken;
Plönes, Till

Publication type:

Article

Patient‐reported outcomes in advanced NSCLC before and during the COVID‐19 pandemic: Real‐world data from the German prospective CRISP Registry (AIO‐TRK‐0315).

Published in:

International Journal of Cancer, 2024, v. 154, n. 11, p. 1967, doi. 10.1002/ijc.34868

By:

Sebastian, Martin;
Eberhardt, Wilfried E. E.;
von der Heyde, Eyck;
Dörfel, Steffen;
Wiegand, Jörg;
Schiefer, Clemens;
Losem, Christoph;
Jänicke, Martina;
Fleitz, Annette;
Zacharias, Stefan;
Kaiser‐Osterhues, Anja;
Hipper, Annette;
Dietel, Corinna;
Bleckmann, Annalen;
Benkelmann, Robin;
Boesche, Michael;
Grah, Christian;
Müller, Annette;
Griesinger, Frank;
Thomas, Michael

Publication type:

Article

Treatment decisions, clinical outcomes, and pharmacoeconomics in the treatment of patients with EGFR mutated stage III/IV NSCLC in Germany: an observational study.

Published in:

2018

By:

Schuette, Wolfgang;
Schirmacher, Peter;
Eberhardt, Wilfried E. E.;
Dietel, Manfred;
Zirrgiebel, Ute;
Muehlenhoff, Lars;
Thomas, Michael

Publication type:

journal article

Neutrophils activate tumoral CORTACTIN to enhance progression of orohypopharynx carcinoma.

Published in:

Frontiers in Immunology, 2013, v. 4, p. 1, doi. 10.3389/fimmu.2013.00033

By:

Dumitru, Claudia A.;
Bankfalvi, Agnes;
Xiang Gu;
Eberhardt, Wilfried E.;
Zeidler, Reinhard;
Lang, Stephan;
Brandau, Sven;
Lai Guan Ng;
Kar Wai Tan

Publication type:

Article

Therapie früher und lokal fortgeschrittener Stadien des nicht-kleinzelligen Lungenkarzinoms.

Published in:

Der Internist, 2022, v. 63, n. 7, p. 717, doi. 10.1007/s00108-022-01366-0

By:

Wiesweg, Marcel;
Eberhardt, Wilfried E.;
Schuler, Martin;
Plönes, Till

Publication type:

Article

Long-term survival of patients with central or > 7 cm T4 N0/1 M0 non-small-cell lung cancer treated with definitive concurrent radiochemotherapy in comparison to trimodality treatment.

Published in:

2022

By:

Guberina, Nika;
Pöttgen, Christoph;
Schuler, Martin;
Guberina, Maja;
Stamatis, Georgios;
Plönes, Till;
Metzenmacher, Martin;
Theegarten, Dirk;
Gauler, Thomas;
Darwiche, Kaid;
Aigner, Clemens;
Eberhardt, Wilfried E. E.;
Stuschke, Martin

Publication type:

journal article

Prediction of malignant lymph nodes in NSCLC by machine-learning classifiers using EBUS-TBNA and PET/CT.

Published in:

Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-21637-y

By:

Guberina, Maja;
Herrmann, Ken;
Pöttgen, Christoph;
Guberina, Nika;
Hautzel, Hubertus;
Gauler, Thomas;
Ploenes, Till;
Umutlu, Lale;
Wetter, Axel;
Theegarten, Dirk;
Aigner, Clemens;
Eberhardt, Wilfried E. E.;
Metzenmacher, Martin;
Wiesweg, Marcel;
Schuler, Martin;
Karpf-Wissel, Rüdiger;
Santiago Garcia, Alina;
Darwiche, Kaid;
Stuschke, Martin

Publication type:

Article

Theranostics with somatostatin receptor antagonists in SCLC: Correlation of 68Ga-SSO120 PET with immunohistochemistry and survival.

Published in:

Theranostics, 2024, v. 14, n. 14, p. 5400, doi. 10.7150/thno.98819

By:

Mavroeidi, Ilektra Antonia;
Romanowicz, Anna;
Haake, Tristan;
Wienker, Johannes;
Metzenmacher, Martin;
Darwiche, Kaid;
Oezkan, Filiz;
Bölükbas, Servet;
Stuschke, Martin;
Umutlu, Lale;
Opitz, Marcel;
Nader, Michael;
Hamacher, Rainer;
Siveke, Jens;
Winantea, Jane;
Fendler, Wolfgang P.;
Wiesweg, Marcel;
Eberhardt, Wilfried E. E.;
Herrmann, Ken;
Theegarten, Dirk

Publication type:

Article

Works by Eberhardt, Wilfried E. E.

Acquired Resistance to BRAF/MEK Inhibitor Therapy in BRAF-V600-mutated Squamous Cell Lung Cancer: Concurrent Evolvement of PTEN and MEK1 Mutations.

Rapid and Highly Sensitive Detection of Therapeutically Relevant Oncogenic Driver Mutations in EBUS-TBNA Specimens From Patients With Lung Adenocarcinoma.

MET Expression in Advanced Non-Small-Cell Lung Cancer: Effect on Clinical Outcomes of Chemotherapy, Targeted Therapy, and Immunotherapy.

Assessment of Folate Receptor-[alpha] and Epidermal Growth Factor Receptor Expression in Pemetrexed-Treated Non-Small-Cell Lung Cancer Patients.

Assessment of Folate Receptor-α and Epidermal Growth Factor Receptor Expression in Pemetrexed-Treated Non-Small-Cell Lung Cancer Patients.

ERCC1, MLH1, MSH2, MSH6, and βIII-Tubulin: Resistance Proteins Associated With Response and Outcome to Platinum-based Chemotherapy in Malignant Pleural Mesothelioma.

Patterns of nodal spread in stage III NSCLC: importance of EBUS-TBNA and <sup>18</sup>F-FDG PET/CT for radiotherapy target volume definition.

<sup>68</sup>Ga-SSO-120 PET for Initial Staging of Small Cell Lung Cancer Patients: A Single-Center Retrospective Study.

PROGNOSTIC VALUE OF POST-INDUCTION CHEMOTHERAPY VOLUMETRIC PET/CT PARAMETERS FOR STAGE IIIA/B NON-SMALL CELL LUNG CANCER PATIENTS RECEIVING DEFINITIVE CHEMORADIOTHERAPY.

PROGNOSTIC VALUE OF POST-INDUCTION CHEMOTHERAPY VOLUMETRIC PET/CT PARAMETERS FOR STAGE IIIA/B NON-SMALL CELL LUNG CANCER PATIENTS RECEIVING DEFINITIVE CHEMORADIOTHERAPY.

PROGNOSTIC VALUE OF POST-INDUCTION CHEMOTHERAPY VOLUMETRIC PET/CT PARAMETERS FOR STAGE IIIA/B NON-SMALL CELL LUNG CANCER PATIENTS RECEIVING DEFINITIVE CHEMORADIOTHERAPY.

PROGNOSTIC VALUE OF POST-INDUCTION CHEMOTHERAPY VOLUMETRIC PET/CT PARAMETERS FOR STAGE IIIA/B NON-SMALL CELL LUNG CANCER PATIENTS RECEIVING DEFINITIVE CHEMORADIOTHERAPY.

PROGNOSTIC VALUE OF POST-INDUCTION CHEMOTHERAPY VOLUMETRIC PET/CT PARAMETERS FOR STAGE IIIA/B NON-SMALL CELL LUNG CANCER PATIENTS RECEIVING DEFINITIVE CHEMORADIOTHERAPY.

PROGNOSTIC VALUE OF POST-INDUCTION CHEMOTHERAPY VOLUMETRIC PET/CT PARAMETERS FOR STAGE IIIA/B NON-SMALL CELL LUNG CANCER PATIENTS RECEIVING DEFINITIVE CHEMORADIOTHERAPY.

Impact of metallothionein-knockdown on cisplatin resistance in malignant pleural mesothelioma.

Long-Term Survival in Patients with Oligometastatic Non-Small Cell Lung Cancer by a Multimodality Treatment—Comparison with Stage III Disease.

Gene expression profiling of homologous recombination repair pathway indicates susceptibility for olaparib treatment in malignant pleural mesothelioma in vitro.

C-reactive protein as robust laboratory value associated with prognosis in patients with stage III non-small cell lung cancer (NSCLC) treated with definitive radiochemotherapy.

N-staging in large cell neuroendocrine carcinoma of the lung: diagnostic value of [18F]FDG PET/CT compared to the histopathology reference standard.

Patient‐reported outcomes in advanced NSCLC before and during the COVID‐19 pandemic: Real‐world data from the German prospective CRISP Registry (AIO‐TRK‐0315).

Treatment decisions, clinical outcomes, and pharmacoeconomics in the treatment of patients with EGFR mutated stage III/IV NSCLC in Germany: an observational study.

Neutrophils activate tumoral CORTACTIN to enhance progression of orohypopharynx carcinoma.

Therapie früher und lokal fortgeschrittener Stadien des nicht-kleinzelligen Lungenkarzinoms.

Long-term survival of patients with central or > 7 cm T4 N0/1 M0 non-small-cell lung cancer treated with definitive concurrent radiochemotherapy in comparison to trimodality treatment.

Prediction of malignant lymph nodes in NSCLC by machine-learning classifiers using EBUS-TBNA and PET/CT.

Theranostics with somatostatin receptor antagonists in SCLC: Correlation of <sup>68</sup>Ga-SSO120 PET with immunohistochemistry and survival.